一品红：产品拟中选全国中成药采购联盟集中带量采购

Core Viewpoint - Yipinhong (300723) announced that its wholly-owned subsidiary has been selected for centralized procurement of traditional Chinese medicine products, indicating a significant opportunity for revenue growth in the healthcare sector [1] Group 1: Company Information - Yipinhong's subsidiary has been selected for the centralized procurement of two products: injectable Yanhuning and Shengmai Drink (Dangshen formula) [1] - The selected price for injectable Yanhuning is 2.20 yuan per bottle, which is intended for the treatment of viral pneumonia and upper respiratory infections [1] - The selected price for Shengmai Drink (Dangshen formula) is 9.60 yuan for a pack of 6, aimed at treating Qi and Yin deficiency, palpitations, shortness of breath, and spontaneous sweating [1] Group 2: Industry Context - The selection for centralized procurement reflects a growing trend in the healthcare industry towards cost-effective treatment options, particularly in traditional Chinese medicine [1] - The pricing strategy for these products may enhance their competitiveness in the market, potentially leading to increased sales volume [1]